US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
カナダ
TSX
Knight Therapeutics Inc (GUD)
Knight Therapeutics Inc (GUD) ニュース

GUD

Knight Therapeutics (GUD)

Knight Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:TSX:GUD

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/08/11	00 : 00	AllPennyStocks.com	Trading For This Specialty Pharma Company is up Following Second Quarter Results	TSX:GUD	Knight Therapeutics Inc
2021/05/13	22 : 38	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation - GUD	TSX:GUD	Knight Therapeutics Inc
2021/05/13	22 : 37	PR Newswire (Canada)	IIROC Trade Resumption - GUD	TSX:GUD	Knight Therapeutics Inc
2021/05/13	21 : 25	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - GUD	TSX:GUD	Knight Therapeutics Inc
2021/05/13	21 : 24	PR Newswire (Canada)	IIROC Trading Halt - GUD	TSX:GUD	Knight Therapeutics Inc
2021/05/03	19 : 00	PR Newswire (Canada)	Maverix Private Equity Announces Team Additions	TSX:GUD	Knight Therapeutics Inc
2021/05/03	19 : 00	PR Newswire (US)	Maverix Private Equity Announces Team Additions	TSX:GUD	Knight Therapeutics Inc
2020/12/12	07 : 15	PR Newswire (Canada)	S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index	TSX:GUD	Knight Therapeutics Inc
2020/12/12	07 : 15	PR Newswire (Canada)	S&P Dow Jones Indices annonce des modifications à l'indice composé S&P/TSX	TSX:GUD	Knight Therapeutics Inc
2020/01/08	22 : 00	PR Newswire (US)	Knight Partners With Debiopharm for the Commercialization of Trelstar® in Canada	TSX:GUD	Knight Therapeutics Inc
2019/06/19	06 : 00	PR Newswire (US)	Medimetriks Pharmaceuticals Focuses on Advancing MM36 (difamilast) Through Phase 3 Trials; Extinguishes Debt Owed to Knight T...	TSX:GUD	Knight Therapeutics Inc
2019/04/29	21 : 45	PR Newswire (Canada)	Medison Urges Fellow Shareholders to Bring Positive Change to Knight Therapeutics by Voting for All Six of Medison's Highly Q...	TSX:GUD	Knight Therapeutics Inc
2019/04/25	23 : 21	PR Newswire (Canada)	Leading Independent Proxy Advisory Firm ISS Recommends Change at Knight Therapeutics	TSX:GUD	Knight Therapeutics Inc
2019/04/18	22 : 00	PR Newswire (Canada)	Medison Issues Presentation to Knight Shareholders	TSX:GUD	Knight Therapeutics Inc
2019/04/17	20 : 00	PR Newswire (Canada)	Leading Canadian Corporate Governance Expert Confirms Acute Board Conflicts and Governance Deficiencies at Knight Therapeutic...	TSX:GUD	Knight Therapeutics Inc
2019/04/16	21 : 30	PR Newswire (Canada)	Medison Issues Letter to Shareholders of Knight Therapeutics, Outlining Qualified, Independent Director Nominees and Common-S...	TSX:GUD	Knight Therapeutics Inc
2019/04/10	21 : 39	PR Newswire (Canada)	Medison Disappointed that Knight Therapeutics has Resorted to Blatant Misrepresentations to Avoid Scrutiny	TSX:GUD	Knight Therapeutics Inc
2019/04/08	21 : 00	PR Newswire (Canada)	Medison Files Proxy Circular, Offers Knight Therapeutics Shareholders Truly Independent, Unconflicted Directors and Comprehen...	TSX:GUD	Knight Therapeutics Inc
2019/04/01	21 : 00	PR Newswire (Canada)	Medison to Nominate Six Highly Qualified Directors for Knight Therapeutics' Board to Strengthen Oversight and Drive Value Cre...	TSX:GUD	Knight Therapeutics Inc
2019/02/18	22 : 30	PR Newswire (US)	Knight Signs GUD (Bueno) Latin American Strategic Funding Deal with Moksha8	TSX:GUD	Knight Therapeutics Inc
2018/03/19	19 : 30	PR Newswire (US)	Ardelyx and Knight Collaborate to Bring Tenapanor to Patients in Canada	TSX:GUD	Knight Therapeutics Inc
2018/02/08	23 : 21	PR Newswire (US)	60° Pharmaceuticals (60P) Receives Priority Review Designation For Malaria Drug	TSX:GUD	Knight Therapeutics Inc
2018/02/08	23 : 03	PR Newswire (US)	60° Pharmaceuticals (60P) Receives Priority Review Designation For Malaria Drug	TSX:GUD	Knight Therapeutics Inc
2018/01/04	23 : 45	PR Newswire (US)	60 Degrees Pharmaceuticals Fast Tracked For Malaria Drug	TSX:GUD	Knight Therapeutics Inc
2017/12/18	23 : 00	PR Newswire (US)	60° Pharmaceuticals (60P) Submits New Drug Application to US FDA for Antimalarial Drug Tafenoquine	TSX:GUD	Knight Therapeutics Inc
2017/08/15	06 : 30	Marketwired	Synergy CHC Corp. Announces Second Quarter 2017 Results	TSX:GUD	Knight Therapeutics Inc
2017/06/13	21 : 03	PR Newswire (Canada)	Braeburn Pharmaceuticals and Knight Therapeutics Announce Filing of New Drug Submission for PROBUPHINE® in Canada for Opioid...	TSX:GUD	Knight Therapeutics Inc
2017/06/13	21 : 03	PR Newswire (US)	Braeburn Pharmaceuticals and Knight Therapeutics Announce Filing of New Drug Submission for PROBUPHINE® in Canada for Opioid...	TSX:GUD	Knight Therapeutics Inc
2016/12/10	08 : 17	PR Newswire (Canada)	Indices S&P Dow Jones annonce des modifications à certains indices canadiens S&P/TSX	TSX:GUD	Knight Therapeutics Inc
2016/03/22	20 : 59	PR Newswire (US)	Profounda, Inc. launches Impavido® (miltefosine), the first and only oral Rx treatment for visceral, mucosal and cutaneous l...	TSX:GUD	Knight Therapeutics Inc

Showing the most relevant articles for your search:TSX:GUD

Gold vs US Dollar

JP Morgan Chase

Financial Select Sector

American Express

Verizon Communications

BNP Paribas (QX)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約